| JXHL0700052 | Eltrombopag olamine片 | eltrombopag olamine | Tablet | Chemical Drugs(1.1) | Import Drug Application | 2007-03-22 | 依格斯（北京）医疗科技有限公司 | Excel Pharma Studies Inc | Certificate Issued | 2007-11-29 | view |
| CXHL1401459 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-11-17 | 武汉药谷生物工程有限公司 | Wuhan Yaogu Bioengineering Co Ltd | Certificate Issued | 2016-04-07 | view |
| CXHL1401462 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-11-17 | 武汉药谷生物工程有限公司 | Wuhan Yaogu Bioengineering Co Ltd | Certificate Issued | 2016-04-07 | view |
| CXHL1401460 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-11-17 | 武汉药谷生物工程有限公司 | Wuhan Yaogu Bioengineering Co Ltd | Certificate Issued | 2016-04-07 | view |
| CXHL1401461 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-11-17 | 武汉药谷生物工程有限公司 | Wuhan Yaogu Bioengineering Co Ltd | Certificate Issued | 2016-04-07 | view |
| JYHB1800370 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-03-28 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2018-04-12 | view |
| JYHB1800371 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-03-28 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2018-04-12 | view |
| JYHB1800372 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-04-11 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2018-08-09 | view |
| JYHB1800373 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-04-11 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2018-08-09 | view |
| JYHB1800798 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-07-20 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2018-09-04 | view |
| JYHB1800797 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-07-20 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2018-09-04 | view |
| JYHB1900562 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2019-05-22 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2019-07-17 | view |
| JYHB1900971 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2019-09-07 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2019-11-19 | view |
| JYHB1900972 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2019-09-25 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Certificate Issued | 2019-11-19 | view |
| CYHS2000074 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(4) | Generic Drug | 2020-01-23 | 江苏奥赛康药业有限公司 | Jiangsu Aosaikang Pharmaceutical Co Ltd | In Review | 2020-01-22 | view |
| JXHL2000038 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-02-26 | Novartis Pharmaceuticals Corporation | Novartis Pharmaceuticals Corporation | In Review | 2020-02-25 | view |
| JXHL2000037 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-02-26 | Novartis Pharmaceuticals Corporation | Novartis Pharmaceuticals Corporation | In Review | 2020-02-25 | view |
| JYHB2000526 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-04-29 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-05-12 | view |
| JYHB2000527 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-04-29 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-05-12 | view |
| JYHB2000592 | 艾曲泊帕乙醇胺片 | eltrombopag olamine | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-05-15 | Novartis Pharma Schweiz AG | Novartis Pharma Schweiz AG | Filed | 2020-05-26 | view |
